• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX ACCULINK CAROTID STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX ACCULINK CAROTID STENT SYSTEM Back to Search Results
Catalog Number UNKNOWN RX ACCULINK
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Embolism (1829); Myocardial Infarction (1969); Neurological Deficit/Dysfunction (1982); Thrombosis (2100); Transient Ischemic Attack (2109); Prolapse (2475)
Event Date 01/01/2019
Event Type  Injury  
Manufacturer Narrative
Date of event: date is estimated.The device was not returned for analysis.The lot history record (lhr) for this product could not be reviewed because the product was not returned for evaluation and the part and lot numbers were not reported.In this case, there was no reported device malfunction associated with the rx acculink.The reported patient effects of myocardial infarction (mi), embolism, neurological deficit / dysfunction, cerebrovascular accident, transient ischemic attack, and thrombosis are listed in the rx acculink instructions for use as known potential patient effects associated with the use of a stent in carotid arteries.Based on the case information, a conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.Literature attached: "stenting of the carotid artery with cguard and acculink stents: interim results of a randomized trial.".
 
Event Description
It was reported through a research article an acculink stent may be related to acute impairment of cerebral circulation, myocardial infarction (mi), neurological deficit, ischemic foci, embolization, cerebral ischemia, and cerebral ischemic stroke.There was no device malfunction reported.Specific patient information is documented as unknown.Details provided in the attached article titled: "stenting of the carotid artery with cguard and acculink stents: interim results of a randomized trial.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX ACCULINK CAROTID STENT SYSTEM
Type of Device
CAROTID STENT
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key11111539
MDR Text Key225102024
Report Number2024168-2021-00030
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeRS
PMA/PMN Number
P040012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 01/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/04/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKNOWN RX ACCULINK
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/15/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability;
Patient Age68 YR
-
-